MTOR and breast carcinoma: Our previous study revealed that DEPDC1 was exclusively associated with the PI3K/AKT/mTOR signaling pathway in breast cancer, and key genes involved in the activation of this pathway were enriched in patients with elevated DEPDC1 expression (28).